Page 49 - Dermatitis News Today

Dr David Rosmarin reviewed several biologics in clinical trials that target interleukin-4 and other receptors.

In the phase 2 study, researchers at 34 sites in four countries randomized 104 patients with mild to moderate AD or psoriasis to receive the topical PDE4 inhibitor or a vehicle once daily for 6 weeks.

"It can be overwhelming because there are many choices but so little time," says Dr Jonathan Silverberg, of George Washington University, Washington, DC.

Upadacitinib trials in atopic dermatitis have included diverse patient groups with varying risk factors, according to Dr Christopher Bunick.

Adults with AD have a significant and disease severity–dependent increased risk of developing ocular surface diseases, including conjunctivitis and keratitis.

The rapid increase in intradermal injections of hyaluronic acid and Botox has been accompanied by an increase in side effects.

Ali Al-Janabi, MA, and associates found that 273 (1%) of approximately 25,000 drug exposures in 13,699 biologic-treated patients with psoriasis were associated with paradoxical eczema.

Dermatitis or eczema skin inflammation symptoms can be reduced by several home remedies like neem, turmeric, aloe vera, herbs, oil, sandalwood paste, vitamin D.

Patients in the roflumilast group showed significant improvements in all secondary endpoints, including itching, scaling, and erythema.

Expert advanced practice providers in dermatology discuss the diagnosis of atopic dermatitis.